Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients-Reference-Cited by-同舟云学术

Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients

Published:2025-06-05 Issue:7 Volume:8 Page:2009-2017
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Zudeh Giulia¹²^ORCID,Franzin Martina¹²,Lucafò Marianna³⁴,Bramuzzo Matteo⁵²,Curci Debora¹²,Yang Jun J.⁶⁷,Maillard Maud⁶⁷,Decorti Giuliana⁸⁴,Stocco Gabriele¹²⁸⁴

Affiliation:

1. Department of Translational and Advanced Diagnostics

2. Institute for Maternal and Child Health I.R.C.C.S. Burlo Garofolo

3. Department of Life Sciences

4. University of Trieste

5. Department of Gastroenterology, Digestive Endoscopy and Nutrition Unit

6. Department of Pharmacy and Pharmaceutical Sciences

7. St. Jude Children’s Research Hospital

8. Department of Medical, Surgical and Health Sciences

Funder

Ministero della Salute

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.5c00135

Reference33 articles.

1. Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes

2. Pediatric Global Health in Children with Very Early-Onset Inflammatory Bowel Disease

3. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies

4. Differences in the management of pediatric and adult onset ulcerative colitis — lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis

5. Effective long-term solution to therapeutic remission in Inflammatory Bowel Disease: Role of Azathioprine